TREATING COCAINE-USING METHADONE PATIENTS: PREDICTORS OF OUTCOMES IN A PSYCHOSOCIAL CLINICAL TRIAL
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Subjects: | |
| Online Access: | Path |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: TREATING COCAINE-USING METHADONE PATIENTS: PREDICTORS OF OUTCOMES IN A PSYCHOSOCIAL CLINICAL TRIAL
- USEFUL PREDICTORS OF OUTCOME IN METHADONE-TREATED PATIENTS: RESULTS FROM A CONTROLLED CLINICAL TRIAL WITH THREE DOSES OF METHADONE.
- COST EFFECTIVENESS OF DISULFIRAM: TREATING COCAINE USE IN METHADONE-MAINTAINED PATIENTS
- CLINICAL EFFICACY OF GABAPENTIN VERSUS TIAGABINE FOR REDUCING COCAINE USE AMONG COCAINE DEPENDENT METHADONE TREATED PATIENTS
- TIAGABINE INCREASES COCAINE-FREE URINES IN COCAINE-DEPENDENT METHADONE-TREATED PATIENTS. RESULTS OF A RANDOMIZED PILOT STUDY
- DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
- KETOCONAZOLE INCREASES COCAINE AND OPIOID USE IN METHADONE MAINTAINED PATIENTS